JOBST Ranked #1 Physician Recommended Compression Therapy Brand in US

Charlotte, North Carolina, UNITED STATES

CHARLOTTE, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- BSN medical, a global provider of integrated medical therapy solutions, today announced that its JOBST® compression therapy line has been ranked the number one physician recommended brand in the United States among American Medical Association physicians who recommend a brand, according to a survey conducted by SERMO, the world’s largest healthcare professional polling company.

Conrad Jobst, a sufferer of varicose veins who developed elastic stockings with optimal fit and gradient pressure, founded JOBST in 1950. Today, BSN medical, formerly BSN-JOBST, continues to honor Jobst’s legacy of innovation with the same commitment to offering compression products that provide performance, comfort and confidence for people suffering from vascular insufficiencies and/or lymphedema.

“Telling my patients the personal story of Conrad Jobst and his invention is a powerful education tool, which helps me to concretely explain the need for wearing graduated JOBST stockings,” said Fedor Lurie, MD, associate director of the JOBST Vascular Institute in Toledo, Ohio, and an adjunct research professor at the University of Michigan.

“Conrad Jobst had severe chronic venous disease (CVD) and he noticed that his leg felt much better when he stood in the swimming pool,” continued Dr. Lurie. “His engineering mind immediately connected this with the graduated hydrostatic pressure of the water, so he designed a stocking that worked exactly like the water in the pool.”

BSN provides a broad range of therapeutic solutions to address prevention and management of CVD and lymphatic disorders. The JOBST compression therapy line, offering a wide assortment of products and solutions designed to relieve symptoms without compromise to lifestyle, was first ranked the US’ number one physician recommended brand back in 2000.

“We are extremely proud to hold our rank as the number one physician recommended compression therapy brand in the US,” said Tyler Palmer, vice president of sales & marketing for JOBST Venous & Lymphatic Solutions USA at BSN medical. “The dedication of Conrad Jobst to create a better solution led to the birth of modern compression therapy. That same dedication to innovation, coupled with a continued pursuit to develop effective therapeutic solutions and engineer comfortable products with relevant features for patients, is even stronger today. It is for this reason that JOBST is the most physician recommended brand above all other manufacturers, and why patients feel confident when wearing our JOBST products.”

About CVD and Lymphedema
CVD refers to other chronic conditions related to or caused by veins that become diseased or abnormal. These problems can include varicose veins and spider veins, leg swelling and leg pain, chronic venous insufficiency, leg skin changes, leg ulcers, phlebitis and vascular malformations1. CVD is a very common problem, with varicose veins affecting more than 25 million adults in the US, and more than six million adults with more advanced venous disease2. Lymphedema is a chronic condition that affects 3-5 million Americans3. It is swelling in one or more extremities resulting from impaired flow of the lymphatic system. In the U.S. and Western countries, lymphedema occurs most commonly as a complication of lymph node dissection for cancer treatment4.

JOBST aims to improve the quality of life for those suffering from venous and lymphatic diseases. It provides a number of compression garments designed to offer highly effective, therapeutic compression for the management of diseases including varicose veins, deep vein thrombosis, chronic venous insufficiency, peripheral edema and lymphedema. This includes the extensive JOBST product range, which comprises ready-to-wear, custom-fit, circular-knit and flat-knit garments for the upper and lower limbs.

About BSN medical – An Essity company
BSN medical is a global leader in wound care & related vascular diseases, lymphology and non-invasive orthopedic products. BSN aims to provide an integrated therapy-driven approach – grounded in a broad portfolio of products, enhanced by insights into current therapeutic areas and complemented by a progressive approach to partnerships. Its well-known brands such as Leukoplast®, Cutimed®, JOBST®, Delta Cast®, Delta Lite® and Actimove® are among the most trusted in healthcare. With its comprehensive product portfolio, BSN medical addresses patients’ needs in the most prevalent conditions in wound care and vascular diseases and orthopedic treatments. BSN medical was acquired by Essity AB (former SCA) in April 2017.

About Essity
Essity is a leading global hygiene and health company that develops, produces and sells Personal Care (Baby Care, Feminine Care, Incontinence Products and Medical Solutions), Consumer Tissue and Professional Hygiene products and solutions. Our vision is: Dedicated to improving well-being through leading hygiene and health solutions. Sales are conducted in approximately 150 countries under many strong brands, including the leading global brands TENA and Tork, and other brands, such as Leukoplast, Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa. Essity has about 48,000 employees and net sales in 2016 amounted to approximately SEK 101bn (EUR 10.7bn). The business operations are based on a sustainable business model with focus on value creation for people and nature. The company has its headquarters in Stockholm, Sweden, and is listed on Nasdaq Stockholm. Essity used to be part of the SCA Group. More information may be found at and

Media Contact in the US:
Amy Cook

Media Contact BSN medical:
Friederike Herrfurth
Director Communications
+49 162 401 06 50

2 Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175184.
3 Foldi M, Foldi E. Foldi’s Textbook of Lymphology for Physicians and Lymphedema Therapists. Maryland Heights, MO: Mosby Elsevier; 2006.
4 Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer 1998;83(12 Suppl American):2776–2781.